An Open -Label, Single-treatment , single period, single dose, clinical phase 1 study to asess the safety and tolerability of hepatitis B vaccine(r-DNA)I. P of M/s Cadila Healthcare Ltd, India in healthy , adult, male, human subjects.

Trial Profile

An Open -Label, Single-treatment , single period, single dose, clinical phase 1 study to asess the safety and tolerability of hepatitis B vaccine(r-DNA)I. P of M/s Cadila Healthcare Ltd, India in healthy , adult, male, human subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs Hepatitis B vaccine recombinant (Primary)
  • Indications Hepatitis B
  • Focus Adverse reactions
  • Sponsors Cadila Healthcare
  • Most Recent Events

    • 02 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top